PDLIM7 and lymphoma: Furthermore, AKT, NF-κB and STAT3 signaling are required for the growth of lymphomas driven by the expression of Epstein-Barr Virus latent membrane protein 1 (EBV-LMP1) [50], and also for the survival of chronic lymphocytic leukemia (CLL) B cells [51].